Astrana Health, Inc.
Income Statement
| Line Item | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $519.9M | $356.4M | $305.9M | $33.0M | $10.5M | $7.8M | $5.1M | $3.9M |
| Cost of Revenue | $361.1M | $273.5M | — | — | — | — | — | — |
| Gross Profit | $158.8M | $82.9M | — | — | $1.4M | $1.5M | $978.4K | $581.9K |
| Gross Margin | 30.5% | 23.3% | — | — | 13.4% | 18.8% | 19.1% | 14.9% |
| Operating Expenses | ||||||||
| Research & Development | — | — | — | — | — | — | — | — |
| SG&A Expense | $43.4M | $26.2M | $21.0M | $11.3M | $5.3M | $3.5M | $1.4M | $566.6K |
| Operating Income | $88.4M | $35.1M | $11.7M | $-694.3K | $-3.9M | $-2.1M | $-413.3K | $4.0K |
| Operating Margin | 17.0% | 9.9% | 3.8% | -2.1% | -37.3% | -26.7% | -8.1% | 0.1% |
| Interest Expense | $561.0K | $79.7K | $61.6K | $1.3M | $679.2K | $930.2K | $304.0K | $126.4K |
| Pretax Income | $82.6M | $49.7M | $18.8M | $-1.2M | $-4.5M | $-8.9M | $-714.5K | $-154.7K |
| Income Tax Expense | $22.4M | $3.9M | $8.8M | $163.8K | $19.5K | $4.8K | $5.8K | $1.6K |
| Net Income | $10.8M | $25.8M | $11.5M | $-1.8M | $-5.0M | $-8.9M | $-720.3K | $-156.3K |
| Net Margin | 2.1% | 7.2% | 3.7% | -5.5% | -47.9% | -114.5% | -14.1% | -4.0% |
| EPS (Basic) | $0.33 | $1.01 | $0.46 | $-0.37 | $-1.37 | $-0.27 | $-0.02 | $-0.01 |
| EPS (Diluted) | $0.29 | $0.90 | $0.41 | $-0.37 | $-1.37 | $-0.27 | $-0.02 | $-0.01 |
| Shares Outstanding (Basic) | 32.9M | 25.5M | 24.7M | 4.9M | 49.1M | 500.0K | 30.6M | 27.6M |
| Shares Outstanding (Diluted) | 37.9M | 28.7M | 28.0M | 4.9M | 49.1M | 500.0K | 30.6M | 27.6M |
| Dividends Per Share | — | — | — | — | — | — | — | — |